Fermenta FY25 Revenues INR 481.3 cr, up 39% YoY; Net Profit INR 76.4 cr vs year-ago loss
PRNewswire
Mumbai (Maharashtra) [India], May 29: Fermenta Biotech Limited, India's leading manufacturer of premium-grade APIs, intermediates, and mixes of vitamins and minerals for the global markets, today announced that its consolidated revenue (other than from real estate) for the financial year ended 31 March 2025 was INR 427.0 crore, up 57% from the same year-ago period; EBITDA for FY25 was INR 83.3 crore against loss of INR 22.3 crore a year ago.Consolidated Revenue for FY25 INR 481.3 crore, up by INR 134 crore YoY. Consolidated EBITDA for FY25 INR 121.6 crore, up 209% YoY. Q4FY25 Consolidated Revenues INR 143.7 crore, up 40% YoY; down 9% QoQ.
Performance highlights
* Human nutrition volume grew by 48% over FY24
* Animal nutrition volume grew by 24% over FY24
* The company successfully completed validation batches for its spray dried (SD) variant of Vitamin D3 100,000 IU/g powder for human nutrition - Vitamin D3 100 SD and started qualification process with leading global customers and regulatory authorities.
* The company also successfully completed commercial scale production of its plant based Vitamin D3 active ingredient using its proprietary technology developed in-house and completed validation batches of its plant based D3 in Oil and D3 spray dried powder variants for human nutrition-Vitadee Green™ 1 MIU Oil and Vitadee Green™ 100 SD and started qualification process with leading global customers and regulatory authorities.
* Fermenta received letter of approval from GAIN, reinforcing its global commitment to quality and nutrition
* Our German subsidiary showed standalone FY25 revenue of INR 38.2 crore, 412% growth from INR 7.5 crore a year ago, with EBITDA of INR 13.9 crore, against loss of INR 9.2 crore a year ago. Our US subsidiary showed revenue of INR 50.4 crore, up 81% from INR 27.8 crore a year ago with EBITDA at INR 0.5 crore loss, against INR 1.6 crore loss a year ago
Commenting on the results, Prashant Nagre, Managing Director, said:
"FY25 marks Fermenta's complete operational turnaround, validating our strategic focus and unwavering commitment to excellence. Strong volume recovery in our core Vitamin D3 business, successful geographic expansion across Latin America and Southeast Asia, and breakthrough innovations like Vitadee Green™--the world's first pharmacopeial-grade plant-based Vitamin D3--demonstrate our resilience and technical leadership.
With strong cash flows, improved margins across all product lines, and new value-added products gaining meaningful market traction, we've built a robust foundation for sustained growth. Our disciplined approach to capital allocation, proactive risk management, and strategic partnerships position us to capitalize on emerging opportunities while advancing our vision of top-quality global nutritional wellness for all."
About Fermenta Biotech Limited
Fermenta Biotech Limited delivers best in class, science-backed nutritional ingredients across a wide range of market segments, including Pharmaceuticals, Dietary Supplements, Food & Beverages, and Veterinary. State-of-the-art manufacturing facilities located at Kullu (Himachal Pradesh) and Dahej (Gujarat) drive FBL's comprehensive portfolio of premium vitamins, nutritional premixes, and ingredients for Human and Animal Nutrition.
Our products and services cater to the exacting standards of the world's leading pharma, dietary supplements and food brands, and veterinary and animal feed producers for best-in-class solutions that enhance health, support preventive care, and drive life productivity. With decades of expertise at global-scale complex manufacturing, we also provide research-based custom solutions in green chemistry and environmental solutions.
Financial Statements can be accessed through this link:
Disclaimer
No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this release. Such information and opinions are in all events not current after the date of this release. Certain statements made in this release may not be based on historical information or facts and may be "forward looking statements" based on the currently held beliefs and assumptions of the management of Fermenta Biotech Limited ("Company" or "FBL" or Fermenta), which are expressed in good faith and in their opinion reasonable, including those relating to the Company's general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company or industry results to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company's business, its competitive environment and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties and other factors, viewers of this release are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments.
This release is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. This release does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. This release is confidential and may not be copied or disseminated, in whole or in part, and in any manner.
For further details, please contact:
For Fermenta Biotech Limited:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
10 hours ago
- Business Standard
Bell Techlogix India Earns 2025 Great Place To Work Certification™ in its First Attempt
VMPL Hyderabad (Telangana) [India], May 30: Bell Techlogix India Private Limited is thrilled to be Certified™ by Great Place To Work® for the first time in 2025. The prestigious award is based entirely on what current employees say about their workplace experience and an outstanding 90% of employees in India said Bell Techlogix is a great place to work - a strong testament to the organization's efforts in creating an inclusive, engaging, and people-first culture from day one. This milestone also coincides with Bell Techlogix earning its third consecutive Great Place To Work Certification™ in the U.S., further solidifying the company's global commitment to its employees. "We are deeply honored to be recognized in our very first attempt," said Angeet Nair, HR Manager for India. "This isn't just about policies or perks - it's about building trust, listening to our people, and evolving with them. We're excited about what we're building here in India." Great Place To Work® is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. "Great Place To Work Certification is a highly coveted achievement that requires consistent and intentional dedication to the overall employee experience," says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work. She emphasizes that Certification is the sole official recognition earned by the real-time feedback of employees regarding their company culture. "By successfully earning this recognition, it is evident that Bell Techlogix stands out as one of the top companies to work for, providing a great workplace environment for its employees." "Seeing both our U.S. and India teams achieve this recognition reinforces our belief that our people are our greatest strength," said Ron Frankenfield, Bell Techlogix CEO. "Culture doesn't happen by accident - it's intentional, and it's thriving across borders." Ami Graves, CHRO of Bell Techlogix, added: "The certification in India marks a defining moment in our global journey. It's a reflection of how our core values transcend geographies. I'm incredibly proud of the India team and their relentless focus on building a great place to work - from the ground up." Bell Techlogix India's certification showcases a holistic workplace where diversity, inclusion, career growth, and employee well-being are deeply valued. According to Great Place To Work research, job seekers are 4.5 times more likely to find a great boss at a Certified great workplace. Additionally, employees at Certified workplaces are 93% more likely to look forward to coming to work, and are twice as likely to be paid fairly, earn a fair share of the company's profits and have a fair chance at promotion. About Bell Techlogix Bell Techlogix, headquartered in Indianapolis, Indiana, provides transformational Next Generation Digital Workplace and Infrastructure Management solutions to large and mid-market enterprises, as well as the public sector. With services that build, integrate, and support the next wave of operational transformation Bell Techlogix provides a true client partnership and an enhanced digital experience. Bell Techlogix provides a flexible approach that is globally capable but locally oriented that will systematically allow you to achieve growth, cost-savings, and acceleration of your business. For more information on Bell Techlogix, please visit us on the web at About Great Place to Work Certification™ Great Place To Work® Certification™ is the most definitive "employer-of-choice" recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience - specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified.
Business Standard
15 hours ago
- Business Standard
PM Narendra Modi inaugurates Kanpur Metro, built by Afcons
PRNewswire Mumbai (Maharashtra) [India], May 30: Prime Minister Narendra Modi on Friday inaugurated a 5-kilometre stretch of the underground Kanpur Metro. Of this, one completed station--Kanpur Central Metro Station--and 2.4 kilometre of tunnelling have been executed by infrastructure major M/s Afcons Infrastructure Ltd. Afcons-led consortium is executing the KNPCC-06 package, which was awarded on March 14, 2022. The project includes design and construction of a 3.826 kilometre underground stretch comprising three metro stations: Kanpur Central, Jhakarkatti, and Transport Nagar, two twin tunnels bored using two shield Tunnel Boring Machines (TBMs), with others. Tunnelling along this stretch posed significant challenges due to the presence of dilapidated buildings. However, Afcons successfully navigated these complexities and completed the tunnelling work safely and efficiently. Construction of Kanpur Central Station, which began in December 2022, and the tunnelling works between Kanpur Central and Nawabganj, initiated in August 2023, have both been completed. Afcons, which has been associated with Kanpur Metro since its early phases, was previously responsible for the Priority Section under package KNPCC-02. This package included an elevated viaduct and nine elevated stations from IIT Kanpur to Motijheel. Afcons completed this section in record time despite the challenges posed by the COVID-19 pandemic. The section was commissioned and opened to the public in June 2021. Afcons is a leader in metro construction in India, with a presence in over 10 cities. The company has executed and delivered complex projects, including India's first underwater tunnel in Kolkata, the country's first four-layer transportation system, a 5.6 kilometre double-decker viaduct for the Nagpur Metro, and one of the largest underground metro stations in India.
Time of India
17 hours ago
- Time of India
Starcom secures McDonald's India West & South media mandate
Starcom India has been awarded the coveted media Agency of Record (AOR) mandate for McDonald's India West and South. This significant win follows a two-decade-long partnership between McDonald's India and Madison , which had handled the account since 2004. The win sees Starcom India taking charge of media planning and buying for the iconic fast-food giant in the crucial West and South markets. While OMD India continues to handle the mandate in the North and East region. The agency bagged the company's North and East region media mandate in 2023. Commenting on the new partnership, Arvind R.P, CMO, McDonald's India (W&S), stated, 'We welcome Starcom India as our new Agency of Record (AOR) for media. Starcom brings a strong blend of strategic thinking and future-forward capabilities across data, digital, and tech, making them well-placed to partner with us on our growth journey. We would also like to thank Madison for a collaborative partnership that has spanned over the past two decades.' In Q4FY25, Westlife Foodworld , the operator of McDonald's restaurants in West and South India, showed a revenue from operations of INR 603.14 crore, marking a 7.3 percent year-on-year growth. While net profit for the quarter saw a sequential decline to INR 1.52 crore, the company demonstrated a focus on digital sales , which contributed over 75 percent to total sales, and expanded its network by adding 18 new restaurants in Q4, bringing the total to 438 across 69 cities.
